Investor and corporate executive focused on Greater China private markets, combining operating experience in real assets and financial services with portfolio and governance roles. Yuen Man Lee brings strategic capital-allocation expertise across direct investments, joint ventures and secondary transactions, advising boards on growth, risk management and exit planning.
Investor and corporate executive focused on Greater China private markets, combining operating experience in real assets and financial services with portfolio and governance roles. Yuen Man Lee brings strategic capital-allocation expertise across direct investments, joint ventures and secondary transactions, advising boards on growth, risk management and exit planning.
Focuses capital on Greater China private markets, blending operating experience in real assets and financial services with disciplined, value-oriented allocation across direct deals, joint ventures and secondary transactions. Prefers control or governance positions that enable operational value creation and risk mitigation, uses board advisory to drive growth, capital structure optimization and exit readiness. Investment horizon is medium to long-term with pragmatic downside protection, sector focus on real assets, fintech and asset managers, and an emphasis on partner alignment and measurable KPIs.
Focuses capital on Greater China private markets, blending operating experience in real assets and financial services with disciplined, value-oriented allocation across direct deals, joint ventures and secondary transactions. Prefers control or governance positions that enable operational value creation and risk mitigation, uses board advisory to drive growth, capital structure optimization and exit readiness. Investment horizon is medium to long-term with pragmatic downside protection, sector focus on real assets, fintech and asset managers, and an emphasis on partner alignment and measurable KPIs.
| Trades 1653 | Longs Won 892/1653 53% | Profit Factor 3.98 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $925,693.51 |
| Average Win $233,817.66 | Best Trade (Jun 30) $26.31M | Sharpe Ratio -11.04 |
| Average Loss -$68,905.31 | Worst Trade (Aug 25) -$5.76M | Z-Score -3.26 (100%) |
| Commissions $0 | Avg. Trade Length 4m 1w 3d | Expectancy $94,451.55 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.09% |
| Consecutive Losing Trades | 4,425 | 3,982 | 3,540 | 3,097 | 2,655 | 2,212 | 1,770 | 1,327 | 885 | 442 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
| 1080 10806XAJ1 | 60,000 | $101,757 | $101,757 | - | - | - | 0.0 |
AA Alcoa Corporation | 7,507 | $391,415 | $376,701.26 | - | -$14,713.74 | -3.76% | +5.687% |
AAOI Applied Optoelectronics, Inc. | 318 | $47,115 | $43,069.92 | - | -$4,045.08 | -8.59% | +9.032% |
AAON Aaon Inc. | 101 | $12,813 | $9,582.88 | - | -$3,230.12 | -25.21% | +5.095% |
ABCB Ameris Bancorp | 160 | $12,478.4 | $14,052.8 | - | $1,574.4 | 12.62% | -0.408% |
ABEO Abeona Therapeutics Inc. | 25,745 | $159,104 | $186,393.8 | - | $27,289.8 | 17.15% | +4.928% |
ABNB Airbnb, Inc. | 911 | $130,364 | $162,239.99 | - | $31,875.99 | 24.45% | +17.443% |
ABSI Absci Corporation | 10,591 | $122,750 | $94,683.54 | - | -$28,066.46 | -22.86% | +7.711% |
ABT Abbott Laboratories | 4,770 | $489,735.95 | $514,253.7 | - | $24,517.75 | 5.01% | -0.139% |
ABVX Abivax SA ADR | 44,256 | $5.53M | $5.79M | - | $261,618.66 | 4.73% | +0.715% |
ACAD Acadia Pharmaceuticals Inc. | 715 | $18,090 | $20,892.3 | - | $2,802.3 | 15.49% | +2.707% |
ACHV Achieve Life Sciences Inc. | 2,780 | $18,153 | $18,487 | - | $334 | 1.84% | +1.527% |
ACMR Acm Research Inc. | 573 | $72,708 | $47,937.18 | - | -$24,770.82 | -34.07% | +5.926% |
ACT Enact Holdings, Inc. | 274 | $12,525 | $12,525 | - | - | - | 0.0 |
ADBE Adobe Inc. | 262 | $53,715 | $69,469.3 | - | $15,754.3 | 29.33% | +1.887% |
ADI Analog Devices, Inc. | 152 | $60,370 | $59,251.12 | - | -$1,118.88 | -1.85% | +3.313% |
ADT ADT Inc. | 414 | $2,691 | $3,158.82 | - | $467.82 | 17.38% | -0.261% |
ADTN Adtran Holdings, Inc. | 2,035 | $30,789.55 | $15,364.25 | - | -$15,425.3 | -50.1% | +0.667% |
ADUR Aduro Clean Technologies Inc. | 1,087 | $17,131 | $17,500.7 | - | $369.7 | 2.16% | +4.886% |
ADUS Addus HomeCare Corporation | 978 | $98,260 | $116,949.24 | - | $18,689.24 | 19.02% | +0.674% |